Across TCGA pan-cancer cohorts, UBE2V1P15 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of UBE2V1P15’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where UBE2V1P15 RNA is repressed in tumor relative to normal tissue. In most cancer types UBE2V1P15 is over-expressed in tumor, although a few such as LUSC and BLCA show the opposite, repressed pattern.

LUSC and BLCA are the cancer types where UBE2V1P15 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UBE2V1P15 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	II,III,IV	−0.078	.002	5	view →
BLCA	All	All	−0.203	.020	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: UBE2V1P15 RNA expression & survival · all UBE2V1P15 data types